Related Experiment Video
Updated: Oct 10, 2025

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues
Petr Lapcik1, Lucia Janacova1, Pavla Bouchalova1
1Department of Biochemistry, Faculty of Science, Masaryk University, Brno, Czech Republic.
Abstract:
Renal cell carcinoma (RCC) represents 2.2% of all cancer incidences; however, prognostic or predictive RCC biomarkers at protein level are largely missing. To support proteomics research of localized and metastatic RCC, we introduce a new library of targeted mass spectrometry assays for accurate protein quantification in malignant and normal kidney tissue. Aliquots of 86 initially localized RCC, 75 metastatic RCC and 17 adjacent non-cancerous fresh frozen tissue lysates were trypsin digested, pooled, and fractionated using hydrophilic chromatography. The fractions were analyzed using LC-MS/MS on QExactive HF-X mass spectrometer in data-dependent acquisition (DDA) mode. A resulting spectral library contains 77,817 peptides representing 7960 protein groups (FDR = 1%). Further, we confirm applicability of this library on four RCC datasets measured in data-independent acquisition (DIA) mode, demonstrating a specific quantification of a substantially increased part of RCC proteome, depending on LC-MS/MS instrumentation. Impact of sample specificity of the library on the results of targeted DIA data extraction was demonstrated by parallel analyses of two datasets by two pan human libraries. The new RCC specific library has potential to contribute to better understanding the RCC development at molecular level, leading to new diagnostic and therapeutic targets.
Insights
Researchers developed a new mass spectrometry assay library for precise protein quantification in renal cell carcinoma (RCC) tissues. This tool aids in identifying potential diagnostic and therapeutic biomarkers for kidney cancer.
Area of Science:
- Proteomics
- Cancer Research
- Biomarker Discovery
Background:
- Renal cell carcinoma (RCC) is a significant cancer, but protein-level biomarkers for prognosis and prediction are scarce.
- Accurate protein quantification in kidney tissues is crucial for advancing RCC research.
Purpose of the Study:
- To create a targeted mass spectrometry assay library for quantifying proteins in malignant and normal kidney tissues.
- To support proteomics research in localized and metastatic RCC.
Main Methods:
- A library of targeted mass spectrometry assays was developed.
- Tissue lysates from localized RCC, metastatic RCC, and adjacent non-cancerous tissues were analyzed.
- Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was employed for data acquisition.
Main Results:
- A spectral library of 77,817 peptides representing 7960 protein groups was generated.
- The library demonstrated applicability for targeted quantification in data-independent acquisition (DIA) datasets.
- Sample specificity of the library improved RCC proteome quantification compared to pan-human libraries.
Conclusions:
- The new RCC-specific library enables more accurate protein quantification in kidney cancer research.
- This resource can advance the understanding of RCC molecular mechanisms.
- It holds potential for identifying novel diagnostic and therapeutic targets for kidney cancer.
More Related Videos
08:08Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017